Dysregulation of PI3K/AKT signaling molecules is frequently associated with different types of cancers such as lung, breast, ovarian, prostate, uterine leiomyomata, and liver cancers [17,18,19,29,30,31]. This evidence concerns the gene AKT1 and liver cancer.